The latest hot news about curcumin, the active ingredient in the curry spice turmeric, is that it may slow the growth of prostate cancer tumors. The results of the pre-clinical study suggest curcumin may be helpful in men with castration-resistant prostate cancer who were taking hormone therapy (androgen deprivation therapy [ADT).
A research team at Thomas Jefferson University’s Kimmel Cancer Center used prostate cancer cells and showed that curcumin suppressed two substances (p300 and CPB) known to work against hormone therapy. In addition, they investigated the use of curcumin in mice and noted prostate cancer tumor growth and mass were significantly reduced in mice dosed with the spice.
